Thanks, Neil and Dave. Revenue for the first quarter came in at $200 million, up 16.3% year-over-year. From a channel perspective, retail revenue increased 24.4% year-over-year, while e-commerce revenue increased 1.8% versus Q1 of 2023. Turning to our stores, we added 41 net new stores over the course of the last 12 months, ending the quarter with 245 stores, up from 204 stores at the end of Q1 2023. This 20% increase in our store count compares to a retail revenue growth of more than 24% over the same period. Looking at Q1 retail performance on a blended basis, including both new stores and stores open greater than 12 months, retail productivity was 102% as compared to the same period last year. As a reminder, we define retail productivity as the year-over-year change in retail sales per store for the average number of stores open in the period. This metric covers all stores open in the period, even new stores open in the last 12 months. Our new stores continue to deliver strong unit economics, performing in line with our target of 35% four-wall margins and 20-month paybacks. 2/3 of our 2022 cohort have now paid back in an average of 17 months, and the cohort as a whole is on track for approximately 20 months. For stores open more than 12 months, average revenue per store was $2.2 million and performance was in line with our target 35% four-wall adjusted EBITDA margins. Over the course of the past year, we added nearly 50 net new eye exam locations, bringing our stores with eye exams to 204, or 83% of our total fleet of 245 stores. From a channel mix perspective, for the first quarter, retail represented 69% of our overall business. This compares to 64% in Q1 2023. From a customer perspective, we finished Q1 with 2.36 million active customers, which we believe is more reflective of active households and represent an increase of 3.2% on a trailing 12-month basis. As we've started anniversarying marketing spend pullbacks in Q2 of last year, we've been pleased to see the sequential improvements in year-over-year active customer growth. Starting in Q2, our trailing 12-month metric will no longer capture periods that had significant marketing spend pullbacks, so we anticipate seeing this metric continue to inflect upward throughout the year. We also continue to see strength in average revenue per customer of $296 in Q1, up 9.6% year-over-year. This was driven by a few factors, including an increase in higher priced lenses, including progressives, and continued ramping of both contact lens and eye exam sales. As previously noted, we have multi-user accounts, in which one person in the household places an order on behalf of others. And if we look at our customers on an individual basis, we served 2.49 million individuals, which is up 4.5% on a trailing 12-month basis and reflects average revenue per individual up 8.3%. Moving on to gross margin. As a reminder, our gross margin is fully loaded and accounts for a range of costs, including frames, lenses, optical labs, customer shipping, optometrist salaries, store rents and the depreciation of store build outs. Our gross margin also includes stock-based compensation expense for our optometrists and optical lab employees. For comparability, I will be speaking to gross margin, excluding stock-based compensation. First quarter adjusted gross margin came in at 56.9% compared to 55.2% in the year ago period. The increase in gross margin was primarily driven by faster growth in our glasses business, which is our highest gross margin product category, efficiencies in our owned optical laboratories, and lower outbound customer shipping costs as a percent of revenue. As expected, we saw stability and modest leverage within the more fixed portion of our cost of goods, including retail occupancy as we've continued to scale our store base. Partially offsetting gross margin leverage in Q1 were higher optometrist salaries as the number of stores offering eye exams grew and continued strength in contact lenses and eye exams, which have lower gross margin profiles than eyeglasses, but over the medium and long term, are accretive to gross profit dollars, which were up 20% year-over-year in Q1. Expanding our contacts offering is a core part of scaling our holistic vision care offering and a key driver of growing average revenue per customer. In addition, contact lenses have a higher purchase frequency and subscription-like purchase cycle. All in all, we're pleased with our gross margin in Q1, and we continue to have confidence in our ability to consistently deliver mid-50s gross margin this year as we expect glasses growth to offset the dilutive effects of contacts and eye exam growth. Shifting gears to SG&A. As a reminder, SG&A for our business includes 3 main components, salary expense for our headquarters, customer experience and retail employees, marketing spend, including our Home Try-On program, and general corporate overhead expenses. Adjusted SG&A excludes non-cash costs like stock-based compensation expense. Adjusted SG&A in the first quarter came in at $103.4 million, or 51.7% of revenue. This compares to Q1 2023 adjusted SG&A of $87.2 million, or 50.7% of revenue. The primary source of deleverage in the quarter was marketing spend increasing as a percent of revenue from 11.7% to 12.4%, while non-marketing SG&A remained flat as a percent of revenue at approximately 39%. In addition, we also saw natural increases in retail salaries as we expanded our store base, as well as investments in fully integrating our new ERP system, which we anticipate will begin to moderate in Q2 and the rest of the year. As a reminder, this year we expect to keep marketing spend in the low-teens as a percent of revenue. Marketing spend for the quarter came in at $24.9 million, or 12.4% of revenue. This is up from $20.1 million and 11.7% of revenue in the same period last year. Turning now to adjusted EBITDA. In the first quarter, we generated adjusted EBITDA of $22.4 million, representing an adjusted EBITDA margin of 11.2%, which compares to adjusted EBITDA of $17.7 million, or 10.3% of revenue in the year-ago period. Turning now to our balance sheet. We were free cash flow positive for the fourth consecutive quarter and ended with a strong balance sheet position reflecting approximately $220 million in cash, which we will continue to deploy deliberately to support our growth and operations. We also have an undrawn credit facility of $120 million that we can increase to $175 million. Now to our outlook. We are encouraged by our momentum year-to-date, but we still are maintaining a conservative stance on guiding our business given the broader macroeconomic environment. Given our performance in Q1, we're revising our full year 2024 guidance higher to the following. Revenue of $753 to $761 million, representing approximately 12.5% to 13.5% year-over-year growth. Adjusted EBITDA of $70 million at the midpoint of our revenue range, which equals an adjusted EBITDA margin of 9.2%. Stability and gross margin in the mid-50s as a percent of revenue, consistent with last year and 40 new store openings. We anticipate adjusted EBITDA margin expansion over the remainder of the year will be driven more by leverage within SG&A as new stores ramp, as we see marketing spend consistent as a percent of revenue, and as we leverage our corporate expense overhead. As a reminder, because of the brand campaign in Q3 last year, we anticipate this year's Q3 will be more profitable than Q2. We anticipate gross margin closer to the mid-50s in line with our full year guidance. We plan to continue to drive growth from both contacts and eye exams and offset the dilutive impact of these offerings by continuing to scale our glasses business, as well as efficiencies achieved through our in-house optical labs. We also expect to see lower year-over-year growth from some of the more fixed components of our COGS stack, including optometrist salaries and store rents. We're still forecasting stock-based compensation as a percentage of net revenue in 2024 to be approximately 6% compared with 10.5% in 2023. Stock-based compensation for both periods is above our long-term forecast as a result of the multi-year equity grants to our co-CEOs in 2021. We still anticipate stock-based compensation to normalize to a range of 2% to 4% of net revenue next year. For Q2 2024, we're guiding to the following. Revenue between $185 million and $187 million, which represents growth of approximately 11.5% to 12.5% year-over-year. Quarter-to-date, we've observed 101% productivity in our retail stores versus the same period last year. As we've seen more consistency in our business across channels, we do not plan to share inter-quarter metrics going forward. Our quarterly guidance reflects our outlook for retail productivity and e-commerce in the relevant period. From a bottom-line perspective in Q2 2024, we're guiding to adjusted EBITDA of approximately $17 million, representing a margin of 9.1% at the midpoint of our range. Thank you again for joining us this morning. With that, Neil, Dave, and I are pleased to take your questions. Operator, please open the line for Q&A.